Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Abstract LB180: SPOC, A highly multiplexed platform to study the kinetics of hundreds of biomolecular interactions: applications for early cancer detection

Rebecca Cook, Chidozie Victor Agu, William Martelly, Peter A. Bell, Mukilan Mohan, Bharath Takulapalli

Cancer Res (2023) 83 (8_Supplement): LB180.

https://doi.org/10.1158/1538-7445.AM2023-LB180

Published: 14 April 2023

View article titled, Abstract LB180: SPOC, A highly multiplexed platform to study the kinetics of hundreds of biomolecular interactions: applications for early cancer detection

Journal Articles

Abstract 2982: Somatic TP53 mutations alter the immune microenvironmentafter chemotherapy in breast cancer

Mellissa J. Nixon, V. Monica Estrada, Susan R. Opalenki, Donna Hicks, Michael Korrer, Melinda E. Sanders, Roberto Salgado, Young Kim, Rebecca Cook, Carlos L. Arteaga, Justin M. Balko

Cancer Res (2018) 78 (13_Supplement): 2982.

https://doi.org/10.1158/1538-7445.AM2018-2982

Published: 01 July 2018

View article titled, Abstract 2982: Somatic TP53 mutations alter the immune microenvironmentafter chemotherapy in breast cancer

Journal Articles

Abstract 4196: Neuregulin signaling in development and transformation of the luminal breast epithelium

David B. Vaught, Donna Hicks, Violeta Sanchez, Rebecca Cook

Cancer Res (2015) 75 (15_Supplement): 4196.

https://doi.org/10.1158/1538-7445.AM2015-4196

Published: 01 August 2015

View article titled, Abstract 4196: Neuregulin signaling in development and transformation of the luminal breast epithelium

Journal Articles

Abstract 511: Rictor/mTORC2 drives formation, progression and therapeutic resistance of HER2-amplified breast cancers

Meghan M. Morrison, Bayley Jones, Violeta Sanchez, Monica V. Estrada, Donna Hicks, Michelle Williams, Dana Brantley-Sieders, Rebecca Cook

Cancer Res (2015) 75 (15_Supplement): 511.

https://doi.org/10.1158/1538-7445.AM2015-511

Published: 01 August 2015

View article titled, Abstract 511: Rictor/mTORC2 drives formation, progression and therapeutic resistance of HER2-amplified breast cancers

Journal Articles

MEK Inhibition Leads to PI3K/AKT Activation by Relieving a Negative Feedback on ERBB Receptors

Alexa B. Turke, Youngchul Song, Carlotta Costa, Rebecca Cook, Carlos L. Arteaga, John M. Asara, Jeffrey A. Engelman

Cancer Res (2012) 72 (13): 3228–3237.

https://doi.org/10.1158/0008-5472.CAN-11-3747

Published: 01 July 2012

View article titled, MEK Inhibition Leads to PI3K/AKT Activation by Relieving a Negative Feedback on ERBB Receptors

Includes: Supplementary data

NARROW

Abstract LB180: SPOC, A highly multiplexed platform to study the kinetics of hundreds of biomolecular interactions: applications for early cancer detection

Abstract 2982: Somatic TP53 mutations alter the immune microenvironmentafter chemotherapy in breast cancer

Abstract 4196: Neuregulin signaling in development and transformation of the luminal breast epithelium

Abstract 511: Rictor/mTORC2 drives formation, progression and therapeutic resistance of HER2-amplified breast cancers

MEK Inhibition Leads to PI3K/AKT Activation by Relieving a Negative Feedback on ERBB Receptors

Email alerts

AACR Journals

Abstract LB180: SPOC, A highly multiplexed platform to study the kinetics of hundreds of biomolecular interactions: applications for early cancer detection

Abstract 2982: Somatic TP53 mutations alter the immune microenvironmentafter chemotherapy in breast cancer

Abstract 4196: Neuregulin signaling in development and transformation of the luminal breast epithelium

Abstract 511: Rictor/mTORC2 drives formation, progression and therapeutic resistance of HER2-amplified breast cancers

MEK Inhibition Leads to PI3K/AKT Activation by Relieving a Negative Feedback on ERBB Receptors

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only